Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of Molecular Genetics on Outcome in Myelofibrosis Patients after Allogeneic Stem Cell Transplantation

4 Apr 2017

Abstract excerpt

Molecular genetics may influence outcome for patients with myelofibrosis. To determine the impact of molecular genetics on outcome after allogeneic stem cell transplantation, we screened 169 patients with primary myelofibrosis (n = 110), post-essential thrombocythemia/polycythemia vera myelofibrosis (n = 46), and myelofibrosis in transformation (n = 13) for mutations in 16 frequently mutated genes. The most...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Kruppel-like factors research
Share to Myeloproliferative Neoplasms: Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28389256
DOI: 10.1016/j.bbmt.2017.03.034

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of Molecular Genetics on Outcome in Myelofibrosis Patients after Allogeneic Stem Cell TransplantationPMID 28389256Read ↗

Targeted Sequencing Improves DIPSS-Plus Prognostic Scoring in Myelofibrosis Patients Undergoing Allogeneic Transplantation.Semantic proximity Read ↗

Genetic Risk Assessment in Myeloproliferative Neoplasms.Semantic proximity Read ↗

Clinical and molecular genetic characterization of myelofibrosis.Semantic proximity Read ↗

Molecular Markers and Prognosis of Myelofibrosis in the Genomic Era: A Meta-analysis.Semantic proximity Read ↗

Transplant Decisions in Patients with Myelofibrosis: Should Mutations Be the Judge?Semantic proximity Read ↗

Allogeneic haematopoietic cell transplantation for myelofibrosis: a real-life perspective.Semantic proximity Read ↗

Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMTSemantic proximity Read ↗

Targeted molecular characterization shows differences between primary and secondary myelofibrosisSemantic proximity Read ↗

Impact of genomic alterations on outcomes in myelofibrosis patients undergoing JAK1/2 inhibitor therapySemantic proximity Read ↗

Precision Medicine Approaches in Acute Myeloid Leukemia with Adverse GeneticsSemantic proximity Read ↗

Impact of allogeneic hematopoietic cell transplant in patients with myeloid neoplasms carrying spliceosomal mutations.Semantic proximity Read ↗

GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.